PMCCPMCCPMCC

Search tips
Search criteria 

Advanced


 
Formats
Article sections
Authors
Related links
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Curr Opin Immunol. Author manuscript; available in PMC 2011 August 1.
Published in final edited form as:
PMCID: PMC2925022
NIHMSID: NIHMS226106
Copyright notice and Disclaimer
Immune memory and aging: An infinite or finite resource?
Janko Nikolich-Zugich1 and Brian D. Rudd
Department of Immunobiology and the Arizona Center on Aging, University of Arizona College of Medicine, 1656 E Mabel St., Tucson, AZ 85719, USA
1 To whom correspondence should be addressed at the above address or via : nikolich/at/email.arizona.edu
Small right arrow pointing to: The publisher's final edited version of this article is available at Curr Opin Immunol
Small right arrow pointing to: See other articles in PMC that cite the published article.
Publisher's Disclaimer
Summary of recent advances
Recent developments in the field of immune memory research and the accumulating literature on age-related alterations in homeostasis, primary and memory T-cell responses make it pertinent to address whether and how memory responses are affected by aging with regard to their generation, maintenance and protective function. New knowledge of T-cell repertoire maintenance over long periods of time, particularly when confronted with persistent pathogen challenge, is now enriched further by studies on whether recent immunological memory can “overfill” and/or constrict prior memory responses. Along with studies on potentiation of memory responses by dietary/metabolic interventions and the recent advances on regulation of primary responses with aging, these findings provide a platform for new approaches to vaccination of older adults.
Adaptive immune responses in the course of a lifespan undergo numerous changes and the last third of lifespan is characterized by well-documented alterations in lymphocyte subset composition, homeostasis and responsiveness. One of the most important characteristics of adaptive immunity, the ability to generate long-lasting, protective immunological memory, is key to the success of long-lived vertebrates in defending against previously encountered infections. Surprisingly, our knowledge of the generation and maintenance of immunological memory in old age is rather incomplete and is generally characterized by the belief that immunological memory functions remain intact with advancing age. While this may be the case when one examines systemic responses of peripheral blood lymphocytes (PBL) with regard to gross parameters of immune responsiveness (e.g. cytokine secretion), more refined and recent studies have indicated that several aspects of these responses could be compromised with aging in mice and humans [1–3]. In this review, we summarize these advances and outline the outstanding questions in the field.
A simplistic summary of our current understanding of aging of the innate and adaptive immune responses is that defects in innate immunity are more variable or less pronounced and still insufficiently understood, whereas defects in adaptive immunity are unambiguous and reproducibly observed in almost any group of mammals in the last third of lifespan. Primary adaptive immune responses, generated by stimulation of naïve T and B cells by new microbial challenge, are the most drastically affected. On the other hand, memory responses to recall challenge appear to suffer less with aging. We will critically examine the latter claim, including intrinsic (cell-autonomous) and extrinsic (environmental) age-related influences that could potentially impact immune memory (Table 1).
Table 1
Table 1
Age-related differences in T cell responses
Typically, the term “intrinsic/cell-autonomous” age-related defect is used to denote shortcomings observed when a given cell type is isolated ex vivo and shown to underperform its adult counterpart in the absence of other cellular partners needed to generate the response. Such defects were described in primary responses of naïve lymphocytes, including the classical discoveries of poor T-cell proliferation and IL-2 production [4–6] made over 30 years ago and thus will not be discussed further. We recently extended these observations using relevant human pathogens (the West Nile virus, WNV and Listeria monocytogenes, LM), showing that primary T-cells in vivo exhibit incomplete effector pathway differentiation, which is likely to be largely cell-autonomous [7,8]. The development of anti-LM resting memory CD8 T cell populations in adult and old C57BL/6 mice (B6) mice were comparable (relative and absolute numbers of antigen-specific CD8+ T cells), regardless of differences in the magnitude of the primary effector CD8 response. Yet upon rechallenge with live Listeria, old LM-memory cells were still inferior in their ability to expand and achieve full effector differentiation [3]. This is reminiscent with the conclusions reached in some, but not all studies using TCR transgenic mice [9,10].
With regard to the maintenance of memory responses generated in youth, Hammerlund et al. demonstrated long-lived memory over many decades (both for T-and B-cells) was achieved in humans naturally infected or vaccinated against smallpox [11]. The functional capabilities of these memory responses were demonstrated in individuals infected with monkeypox, where previously exposed and/or vaccinated individuals experienced only mild or no disease symptoms, including individuals vaccinated 13–43 years before MPXV exposure [11]. Thus, memory responses generated in youth not only persist, but can remain strongly protective in older adults. Importantly, it is possible that a different scenario exists in memory/effector cells specific for latent persistent viruses over the entire lifespan, where cells are receiving periodic restimulation. However, we discovered that long-term memory or effector memory responses against HSV-1 in mice [12] or CMV in monkeys [13] are not affected by aging, either in their functional or proliferative capabilities.
The above studies strongly suggests that T-cell memory, when generated in old animals for the first time, is defective, whereas memory responses established in youth may be much more resilient and better maintained. It remains to be established whether this is strictly due to intrinsic defects or whether extrinsic influences (e.g those from antigen presenting cells, cytokines or other microenvironmental sources) also affect memory formation, maintenance and function.
Lastly, it is important to consider that memory responses may be differentially impacted by aging depending on the anatomical site that is examined. This was elegantly shown by a recent study assessing recall responses to skin antigens [1]. Many old individuals were nonresponsive to T-cell skin tests such as PPD/tuberculin and candida, despite the fact that blood T-cells in these individuals responded strongly to such antigens. The problem was that T-cell localization to the site of cutaneous challenge was impaired. T-cells expressed all the proper migration-related receptors, but cutaneous capillaries were devoid of proper ligands to attract them. This was due to defective TNFα production by cutaneous macrophages. In turn, these macrophages could produce the cytokine if directly stimulated with LPS. That left the primary defect unresolved, and authors speculated that TLR signaling, Treg activity or initial T-cell: monocyte communication could be responsible. These results show that functional systemic memory is not always a reliable indicator of robust tissue-specific responses.
The ability to generate protective immunity against a wide array of pathogens depends on the diversity of T cells. T cell repertoire diversity remains remarkably constant throughout adulthood when new naïve T cells can be produced either from lymphocyte precursors in the thymus or by autoproliferation of existing naïve cells stimulated by IL-7 and other homeostatic cytokines in the periphery. However, with age, the thymus involutes, drastically reducing the generation of new T cells, while the naïve T cell pool continually converts to memory T cells by lifelong homeostatic proliferation and exposure to antigens [14–17]. The diversity of the T cell pool is further compromised by the development of age-associated CD8+ T cell clonal expansions which in mice can comprise >80% of the entire CD8+ T cell compartment [15,17–19]. Altogether, these changes have the potential to precipitate a massive loss of naïve T cells and an overrepresentation of memory T cells that significantly restricts T cell repertoire diversity in old individuals.
Making matters worse, life-long infections with persistent pathogens (e.g. HSV, CMV) result in bouts of viral reactivation, which repeatedly stimulate memory T cells specific for these pathogens and further contribute to the imbalance between naïve and memory T cells [20]. Given that T cell stimulation is intermittent (only during reactivations), these T cells do not exhibit the cardinal signs of exhaustion seen in chronic infections (HCV, HIV), and are usually very efficient in providing immune control. However, over time the pool of memory T cells dedicated to controlling persistent pathogens may continue to expand [21] and can comprise up to 50% of the human memory pool [22]. Recently, it has been estimated that every individual is infected with ~8–12 lifelong viral infections [23], suggesting these types of responses may be normal components of the aging process and should be considered in models of human immune aging.
Several studies have investigated to what extent the naïve T cell compartment is depleted in old age. Naylor et. al demonstrated that in humans CD4 T cell diversity is maintained up to 60 years of age, but is then followed by a dramatic 100 fold decline in diversity after the age of 70[24]. These authors observed a compensatory two fold increase in homeostatic T cell proliferation as thymic output decreased, and the phenotypic distinctions between naïve and memory T cell populations became blurred when this threshold age was reached. Similarly, Ahmed et. al demonstrated a decrease in naïve T cell diversity in old mice (as shown by skewed spectratyping analysis) with evidence of clonal expansions [25]. As these studies were performed in specific pathogen free mice, it would also be informative to repeat these studies in mice harboring persistent viral infections. Altogether, these reports indicate that the age-related decrease in T cell diversity is due to both reduced thymic output and exaggerated activity of homeostatic mechanisms invoked to correct this naive T-cell lymphopenia. Further support for that scenario was obtained in monkeys for CD8+ T-cells [26]. In this study, naïve cells declined with aging, and surprisingly their turnover was increased in old animals, with a clear threshold effect - only when naïve CD8 T-cell pool in blood decreased below 5% of the total, was there pronounced naïve T-cell turnover. While these pioneering studies provide a broad perspective on how aging shapes our T cell compartments, deep sequencing analysis may be required to resolve precisely how the clonotypic structure of the T cell responses is altered within and among older individuals.
One important question is whether age-related changes impact the composition of the naïve T cell compartment in a stochastic manner, or whether there are preferential and predictable biases. For example, it is still not known whether CD8+ T cell epitopes have different lifespans or susceptibilities to aging. A recent study addressed this important question by examining the influence of aging on co-dominant influenza epitopes derived from the viral nucleoprotein (NP366-374) and acid polymerase (PA224-233) proteins [2]. TCR sequencing established that the NP366-specific repertoire was dominated by a few public clonotypes shared among individuals; while the PA224-specific repertoire was much more diverse and individualized [27–31]. Yet the PA224-specific repertoire consisted of ~10 times more naïve precursors [2]. However, the key finding was that old mice (>18 months) preferentially lost the less abundant and more restricted NP366-specific clonotypes. This could indicate that with advancing age, we first shed epitope-specific CD8+ T cells with a low naïve precursor frequency, so that in old age we are only left with the pools of epitope-specific CD8+ T cells that were initially most diverse and abundant.
Recently, a tetramer-enrichment approach has been used to quantify and isolate endogenous antigen-specific T cells from naïve mice [32]. Using this technique, the sizes of epitope specific CD8+ and CD4+ T cell precursor pools were estimated at 80–1200 and 20–200 cells per mouse, respectively [32,33]. Interestingly, Kedl and Jameson examined the phenotype of naïve precursors in young adult mice and found that up to >30% of these naïve precursors already shows signs of extensive homeostatic proliferation and can masquerade as memory T cells [34]. These studies suggest that a significant proportion of our memory compartment, at least in mice, may be derived from homeostatic proliferation rather than exposure to foreign antigens. Moreover, the precursors exhibiting prior signs of homeostatic proliferation were also found to be the more responsive upon stimulation with peptide. It will be important to reexamine the phenotype and functionality of these precursors pools as they become increasingly reliant on homeostatic mechanisms with advancing age. It is possible that epitopes undergoing the fastest rates of homeostatic proliferation may have divided many times and will be those that first become senescent in old age. Therefore, correlating precursor frequency, T cell diversity, rates of homeostatic proliferation, and immune functionality for various epitopes in old individuals should provide us with better guidelines in choosing the most robust targets for vaccination in the elderly,.
The age-related decline in number, diversity and functionality of naïve T cells also presents significant challenges in developing efficacious vaccines for the elderly. Vaccination provides the most successful means for the prevention of infectious disease, but vaccine efficacy plummets in individuals over the age of 65. Finding the correct balance between safety and immunogenicity for vaccine candidates applicable to the elderly becomes substantially more difficult. The more immunogenic live attenuated vaccines (e.g. FluMist, yellow fever vaccine) were associated with increased incidence of complications in the elderly, and are not recommended for use in individuals over 50[35]. Meanwhile, dead or highly attenuated vaccines, like the annual influenza subunit vaccine, show only modest efficacy (~17–53%) in the elderly [36]. These impaired responses against vaccines stem from basic defects that preclude generation of robust primary and likely memory responses against new antigens. Consequently, vaccines tailored for the elderly may require new adjuvants, different routes, doses and regimens of vaccination to generate responses that are comparable to those observed in younger adults.
A number of recent studies have also shed light on factors that are involved in increasing the proportion of effector T cells that develop into memory T cells. Two landmark studies have shown that metabolic pathways are critical in the decision process to become long-lived memory T cells and that a switch from anabolic to catabolic metabolism is necessary for memory differentiation [37,38]. While Arkai et. al. inhibited components of the mTOR pathway, and Pearce et. al. blocked fatty acid metabolism, higher numbers of memory CD8+ T cells were observed in both cases. A better mechanistic understanding of these decision processes may allow us to generate more memory T cells from fewer naïve T cells, and thereby develop new vaccination strategies for the elderly.
Given that diversity is still maintained throughout much of adult life, one possible strategy may be to vaccinate individuals well before the catastrophic crash in T cell diversity is reached. Promise for this approach comes from human studies demonstrating remarkably long-lived persistence of memory B cells (>50 years) and CD8+ T cells (>10 years) following anti-viral vaccination [39–43]. However, the key question is to what extent immunological memory is preserved with subsequent exposure to acute and persistent pathogens. Some of the initial studies argued that there is an upper limit to the memory T cell pool, and that pre-existing memory T cells must be depleted in order to make room for newly formed memory T cells [44]. These conclusions were based on results that showed a significant loss of pre-existing memory T cells, which correlated with the number of subsequent heterologous viral infections. Importantly, these data suggest that administering vaccines too early in life may consequently subject memory T cells to a higher level of attrition.
This paradigm was re-addressed by Vezys et. al., who observed an increase in the total number of CD8+ T cells following heterologous prime-boost immunizations with only modest erosion in numbers of pre-existing memory T cells [45]. The authors concluded that the memory CD8+ T cell compartment is not fixed in size but can accommodate substantial increases in effector memory T cells in the spleen, blood, bone marrow and liver. In similar experiments, Huster et. al confirmed many of these findings, but showed that the protective capacity of pre-existing Listeria-specific effector memory T cells becomes impaired following infection with modified vaccinia virus Ankara [46]. One major difference in infections that ablate pre-existing memory versus those that do not, may relate to the amount of interferon that is produced. Previous studies suggest that interferons (both type I and type II), produced early in infections, results in high levels of memory T cell apoptosis and/or attrition [47–51]. Therefore, it is possible that reduction in numbers and functionality is only observed following infections that produce substantial levels of interferons. Given that persistent infections also result in intermittent production of interferons and generate massive numbers of memory T cells, it will be important to formally determine the long-term impact of these infections on pre-existing memory T cells. Together, these studies underline the need to better understand how an individual’s ‘pathogen resume’ may influence their ability to generate both new and recall T cell responses.
In summary, the most recent advances are showing that memory responses in aging individuals need to be carefully dissected to understand potential vulnerabilities. Long-lived memory responses established in youth tend to survive and function well, albeit tissue-specific coordination of such responses could be compromised. Memory responses generated in the old age are blunted and methods to improve them are necessary. In that regard, fatty acid and rapamycin treatments have been successful in adults and should be examined in elderly. The maintenance of memory T-cell repertoire remains a critical topic.
Overall, we are conceptually moving from the era of empirical vaccination of the elderly and into the vaccination strategies based upon molecular, mechanistic findings that define defects in immunity with the old age. This should start with screening to evaluate availability of naïve and memory cells. Memory formation should be stimulated in vaccine formulations in youth and also in those older adults with sufficient naïve T-cell reserve, whereas immune rejuvenation is likely to be necessary if the naïve reserve drops below critical levels. Definition of intervention thresholds in humans will be key to effective treatments.
Acknowledgments
Authors would like to acknowledge support of the National Institutes of Health, specifically from grant awards AG20719 and AG03319 (National Institute on Aging to J.N-Z.)
Footnotes
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
**1. Agius E, Lacy KE, Vukmanovic-Stejic M, Jagger AL, Papageorgiou AP, Hall S, Reed JR, Curnow SJ, Fuentes-Duculan J, Buckley CD, et al. Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging. J Exp Med. 2009;206:1929–1940. This manuscript shows, using very elegant ex vivo techniques in humans, that coordination of established memory T-cell responses in the skin is altered, even when systemic T-cell immunity to the same antigens remains robus. [PMC free article] [PubMed]
2. Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, Blackman MA. Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med. 2008;205:711–723. [PMC free article] [PubMed]
3. Smithey MJRK, Rudd B, Nikolich-Zugich J. Aging-associated CD8 T-cell defects increase susceptibility to systemic infection with L. monocytogenes. Submitted.
4. Miller RA. Effect of aging on T lymphocyte activation. Vaccine. 2000;18:1654–1660. [PubMed]
5. Effros RB. Replicative senescence of CD8 T cells: effect on human ageing. Exp Gerontol. 2004;39:517–524. [PubMed]
6. Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol. 2004;4:665–674. [PubMed]
**7. Brien JD, Uhrlaub JL, Hirsch A, Wiley CA, Nikolich-Zugich J. Key role of T cell defects in age-related vulnerability to West Nile virus. J Exp Med. 2009;206:2735–2745. Using the newly developed model of West Nile virus infection in mice, authors demonstrate the presence and critical relevance of both quantitative and qualitative defects in the initial development of effector T-cell responses in old animals. [PMC free article] [PubMed]
8. Smithey MJRK, Rudd B, Nikolich-Zugich J. Aging-associated CD8 T-cell defects increase susceptibility to systemic infection with L. monocytogenes. In preparation.
9. Kapasi ZF, Murali-Krishna K, McRae ML, Ahmed R. Defective generation but normal maintenance of memory T cells in old mice. Eur J Immunol. 2002;32:1567–1573. [PubMed]
10. Haynes L, Eaton SM, Burns EM, Randall TD, Swain SL. CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci U S A. 2003;100:15053–15058. [PubMed]
11. Hammarlund E, Lewis MW, Carter SV, Amanna I, Hansen SG, Strelow LI, Wong SW, Yoshihara P, Hanifin JM, Slifka MK. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat Med. 2005;11:1005–1011. [PubMed]
12. Lang A, Nikolich-Zugich J. Maintenance of functional memory against latent persistent infection in aging mice. In preparation.
13. Cicin-Sain LHS, Sylvester A, Siess D, Currier N, Legasse A, Fischer MB, Mori CM, Axthelm MK, Nikolich-Zugich J, Picker LJ. Cytomegalovirus-specific T-cell immunity is not compromised in old rhesus monkeys. In preparation.
14. Hingorani R, Choi IH, Akolkar P, Gulwani-Akolkar B, Pergolizzi R, Silver J, Gregersen PK. Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects. J Immunol. 1993;151:5762–5769. [PubMed]
15. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to “benign monoclonal gammapathy” J Exp Med. 1994;179:609–618. [PMC free article] [PubMed]
16. Schwab R, Szabo P, Manavalan JS, Weksler ME, Posnett DN, Pannetier C, Kourilsky P, Even J. Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol. 1997;158:4493–4499. [PubMed]
17. LeMaoult J, Messaoudi I, Manavalan JS, Potvin H, Nikolich-Zugich D, Dyall R, Szabo P, Weksler ME, Nikolich-Zugich J. Age-related dysregulation in CD8 T cell homeostasis: kinetics of a diversity loss. J Immunol. 2000;165:2367–2373. [PubMed]
18. Callahan JE, Kappler JW, Marrack P. Unexpected expansions of CD8-bearing cells in old mice. J Immunol. 1993;151:6657–6669. [PubMed]
19. Posnett DN, Edinger JW, Manavalan JS, Irwin C, Marodon G. Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28− cytotoxic effector clones. Int Immunol. 1999;11:229–241. [PubMed]
20. Nikolich-Zugich J. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol. 2008;8:512–522. [PubMed]
21. Karrer U, Sierro S, Wagner M, Oxenius A, Hengel H, Koszinowski UH, Phillips RE, Klenerman P. Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol. 2003;170:2022–2029. [PubMed]
22. Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F, Sleath PR, Grabstein KH, Hosken NA, Kern F, et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med. 2005;202:673–685. [PMC free article] [PubMed]
23. Virgin HW, Wherry EJ, Ahmed R. Redefining chronic viral infection. Cell. 2009;138:30–50. [PubMed]
24. Naylor K, Li G, Vallejo AN, Lee WW, Koetz K, Bryl E, Witkowski J, Fulbright J, Weyand CM, Goronzy JJ. The influence of age on T cell generation and TCR diversity. J Immunol. 2005;174:7446–7452. [PubMed]
*25. Ahmed M, Lanzer KG, Yager EJ, Adams PS, Johnson LL, Blackman MA. Clonal expansions and loss of receptor diversity in the naive CD8 T cell repertoire of aged mice. J Immunol. 2009;182:784–792. Repertoire analysis was performed to evaluate the loss of naïve T-cell repertoire in aging mice. Authors demonstrate that influenza virus-specific repertoire is lost in a differentiall manner with aging, with less diverse repertoires being lost earlier. [PMC free article] [PubMed]
26. Cicin-Sain L, Messaoudi I, Park B, Currier N, Planer S, Fischer M, Tackitt S, Nikolich-Zugich D, Legasse A, Axthelm MK, et al. Dramatic increase in naive T cell turnover is linked to loss of naive T cells from old primates. Proc Natl Acad Sci U S A. 2007;104:19960–19965. [PubMed]
27. Kedzierska K, Day EB, Pi J, Heard SB, Doherty PC, Turner SJ, Perlman S. Quantification of repertoire diversity of influenza-specific epitopes with predominant public or private TCR usage. J Immunol. 2006;177:6705–6712. [PubMed]
28. Turner SJ, Kedzierska K, La Gruta NL, Webby R, Doherty PC. Characterization of CD8+ T cell repertoire diversity and persistence in the influenza A virus model of localized, transient infection. Semin Immunol. 2004;16:179–184. [PubMed]
29. Kedzierska K, Turner SJ, Doherty PC. Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope. Proc Natl Acad Sci U S A. 2004;101:4942–4947. [PubMed]
30. Turner SJ, Kedzierska K, Komodromou H, La Gruta NL, Dunstone MA, Webb AI, Webby R, Walden H, Xie W, McCluskey J, et al. Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations. Nat Immunol. 2005;6:382–389. [PubMed]
31. Turner SJ, Diaz G, Cross R, Doherty PC. Analysis of clonotype distribution and persistence for an influenza virus-specific CD8+ T cell response. Immunity. 2003;18:549–559. [PubMed]
32. Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, Kedl RM, Jenkins MK. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity. 2007;27:203–213. [PMC free article] [PubMed]
33. Obar JJ, Khanna KM, Lefrancois L. Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. Immunity. 2008;28:859–869. [PMC free article] [PubMed]
*34. Haluszczak C, Akue AD, Hamilton SE, Johnson LD, Pujanauski L, Teodorovic L, Jameson SC, Kedl RM. The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J Exp Med. 2009;206:435–448. [PMC free article] [PubMed]
35. Betts RF, Treanor JJ. Approaches to improved influenza vaccination. Vaccine. 2000;18:1690–1695. [PubMed]
36. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine. 2006;24:1159–1169. [PubMed]
**37. Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA, Bachmann MF, Larsen CP, Ahmed R. mTOR regulates memory CD8 T-cell differentiation. Nature. 2009;460:108–112. Together with the study below, this study demonstrates highly effective use of metabolic sensing pathways to manipulate and modulate T-cell memory devleoment, opening the possibilities for dietary and other modes of intervention in vaccination. [PMC free article] [PubMed]
**38. Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang LS, Jones RG, Choi Y. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature. 2009;460:103–107. Together with the study above, this study demonstrates highly effective use of metabolic sensing pathways to manipulate and modulate T-cell memory devleoment, opening the possibilities for dietary and other modes of intervention in vaccination. [PMC free article] [PubMed]
39. Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, Sexton GJ, Hanifin JM, Slifka MK. Duration of antiviral immunity after smallpox vaccination. Nat Med. 2003;9:1131–1137. [PubMed]
40. Van Epps HL, Terajima M, Mustonen J, Arstila TP, Corey EA, Vaheri A, Ennis FA. Long-lived memory T lymphocyte responses after hantavirus infection. J Exp Med. 2002;196:579–588. [PMC free article] [PubMed]
41. Nanan R, Rauch A, Kampgen E, Niewiesk S, Kreth HW. A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J Gen Virol. 2000;81:1313–1319. [PubMed]
42. Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol. 2003;171:4969–4973. [PubMed]
43. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357:1903–1915. [PubMed]
44. Selin LK, Lin MY, Kraemer KA, Pardoll DM, Schneck JP, Varga SM, Santolucito PA, Pinto AK, Welsh RM. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity. 1999;11:733–742. [PubMed]
**45. Vezys V, Yates A, Casey KA, Lanier G, Ahmed R, Antia R, Masopust D. Memory CD8 T-cell compartment grows in size with immunological experience. Nature. 2009;457:196–199. Together with the study below (46), these experiments show that hyperimmunization does not lead to numerical attrition of preexisting memory cells. [PubMed]
**46. Huster KM, Stemberger C, Gasteiger G, Kastenmuller W, Drexler I, Busch DH. Cutting edge: memory CD8 T cell compartment grows in size with immunological experience but nevertheless can lose function. J Immunol. 2009;183:6898–6902. Like the study above (45)), these experiments show that hyperimmunization does not lead to numerical attrition of preexisting memory cells. They do, however, caution that preexisting memory cells can lose functionality, assessed by cytokine production, in the face of expansion of new, more recently generated memory cells. [PubMed]
47. McNally JM, Zarozinski CC, Lin MY, Brehm MA, Chen HD, Welsh RM. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J Virol. 2001;75:5965–5976. [PMC free article] [PubMed]
48. Jiang J, Lau LL, Shen H. Selective depletion of nonspecific T cells during the early stage of immune responses to infection. J Immunol. 2003;171:4352–4358. [PubMed]
49. Bahl K, Kim SK, Calcagno C, Ghersi D, Puzone R, Celada F, Selin LK, Welsh RM. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. J Immunol. 2006;176:4284–4295. [PubMed]
50. Jiang J, Gross D, Nogusa S, Elbaum P, Murasko DM. Depletion of T cells by type I interferon: differences between young and aged mice. J Immunol. 2005;175:1820–1826. [PubMed]
51. Dudani R, Murali-Krishna K, Krishnan L, Sad S. IFN-gamma induces the erosion of preexisting CD8 T cell memory during infection with a heterologous intracellular bacterium. J Immunol. 2008;181:1700–1709. [PubMed]